Publications by authors named "Alan List"

Claim this Profile
L
Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with mutant MDS/AML.
David A Sallman, Rami S Komrokji, Amy E Dezern, Marie Sebert, Guillermo Garcia-Manero, Alan F List

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.
Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang, Alan F List

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, John M Bennett, Rafael Bejar, Alan F List

Mod Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti, Alan F List

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Alan F List

Blood Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy.
Janine Overcash, Alan Francis List, Lodovico Balducci

Clin J Oncol Nurs· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1 International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Alan F List

Blood Rev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle arrest: A breakthrough in the supportive care of older cancer patients.
Claire Falandry, Alan List, Lodovico Balducci

J Am Geriatr Soc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Alan F List

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle Arrest.
Lodovico Balducci, Claire Falandry, Alan List

Drugs Aging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological drivers of clinical phenotype in myelofibrosis.
John Mascarenhas, Hélène F E Gleitz, Helen T Chifotides, Claire N Harrison, Srdan Verstovsek, Alan F List

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.
Grace A Ward, Robert P Dalton, Benjamin S Meyer, Amy F McLemore, Amy L Aldrich, Alan F List

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
Lodovico Balducci, Claire Falandry, Alan List

Curr Oncol Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Alan F List

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
Lodovico Balducci, Claire Falandry, Alan List

Curr Oncol Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
Tae-Hoon Shin, Yifan Zhou, Shirley Chen, Stefan Cordes, Max Z Grice, Alan F List

Blood· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes.
Amy F McLemore, Hsin-An Hou, Benjamin S Meyer, Nghi B Lam, Grace A Ward, Alan F List

JCI Insight· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.
Pingyan Cheng, Xianghong Chen, Robert Dalton, Alexandra Calescibetta, Tina So, Alan F List

Mol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning.
David A Sallman, Rafael Bejar, Guillermo Montalban-Bravo, Sandra E Kurtin, Alan F List

Leuk Res Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin.
Chen Wang, Kathy L McGraw, Amy F McLemore, Rami Komrokji, Ashley A Basiorka, Alan F List

Haematologica· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia.
Anthony M Hunter, Hannah Newman, Amy E Dezern, David P Steensma, Sandrine Niyongere, Alan F List

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eprenetapopt (APR-246) and Azacitidine in -Mutant Myelodysplastic Syndromes.
David A Sallman, Amy E DeZern, Guillermo Garcia-Manero, David P Steensma, Gail J Roboz, Alan F List

J Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.
Grace A Ward, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, Benjamin S Meyer, Amy F McLemore, Alan F List

Blood Adv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw Pawel Maciejewski, Alan Francis List

Lancet Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes.
Anthony M Hunter, Rami S Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan, Alan F List

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis